EMBLEM, founded in 1999, is the wholly owned subsidiary and exclusive technology and knowledge transfer partner of the European Molecular Biology Laboratory (EMBL). Based at the EMBL headquarters in Heidelberg (Germany), EMBLEM is responsible for identifying, protecting and commercializing intellectual property and associated technologies and materials developed in the EMBL-world including the outstations Hinxton (U.K.), Hamburg (Germany), Grenoble (France), Rome (Italy), and Barcelona (Spain).
Currently, EMBLEM manages a portfolio in excess of 900 inventions, over 300 patent applications and granted patents, and more than 400 active license contracts with major players in the pharmaceutical, biotech and instrumentation markets.
EMBLEM’s technology portfolio spans the Life Sciences in the broadest sense and includes enabling technologies, molecular tools & techniques, instruments & devices as well as software programmes & databases.